Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Patch testing is crucial to reduce allergic reactions in hair loss treatments.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

88% phenol is effective for treating alopecia areata.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Viddhakarma may effectively regrow hair in alopecia areata without side effects.

Alopecia areata is more common in males, mostly affects the scalp, and often appears as patchy hair loss.

Alopecia areata patients have more Propionibacterium acnes and less Staphylococcus epidermidis on their scalps.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

A woman's hair loss led to discovering she had lupus.

Having asthma, atopic dermatitis, or Hashimoto's thyroiditis increases the risk of severe and long-lasting alopecia areata.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Alopecia areata in children shows varied forms and treatment challenges, with some achieving full or partial hair regrowth.

Vitiligo and alopecia should be covered by Medicaid and TRICARE as medical, not cosmetic, conditions.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

A boy with Pachyonychia congenita has a confirmed gene mutation, highlighting the need for a local genetic database in India.

Hair loss can be caused by hormones, illness, autoimmune disorders, or vitamin deficiencies, and treatments vary depending on the type.

Micronutrient deficiencies might contribute to alopecia areata.

A girl with a rare genetic condition affecting hair and nails also developed a common type of hair loss, suggesting a possible genetic link.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

Monilethrix, a genetic hair disorder causing fragile hair, affects three generations in a family.

Many women's hair loss is due to health issues, medication, nutrition, or stress.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Dermoscopy is useful for diagnosing lichen planopilaris and certain features may relate to disease duration, age, and gender.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.